Skip to main content
Erschienen in: Digestive Diseases and Sciences 1/2016

01.01.2016 | Original Article

Functional Gastrointestinal Symptoms Are Associated with Higher Serum Total IgE Levels, but Less Atopic Sensitization

verfasst von: Ellen Johanne Vara, Cecilie Svanes, Trude D. Skorge, Aud Berstad, Erik Florvaag, Debbie Jarvis, Ernst Omenaas, Marie Waatevik, Ane Johannessen, Gülen Arslan Lied

Erschienen in: Digestive Diseases and Sciences | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

The relation of gastrointestinal (GI) complaints to IgE-mediated allergy is not well understood. Increased numbers of “IgE-armed” mast cells have been observed in duodenal mucosa of patients with functional GI complaints.

Aims

To explore whether total IgE and atopic sensitization were associated with functional GI complaints.

Methods

Levels of serum total and specific IgE and GI complaints were measured in 161 patients and in a general population sample of 478 persons. Standard inhalant allergens were measured in the patient group, and selected inhalant allergens in the general population. GI complaints were assessed by two standardized questionnaires. The associations between GI complaints and total IgE were analyzed in multiple regression models.

Results

GI complaints were positively associated with higher total IgE levels (all: b = 0.028, p = 0.012; patient group: b = 0.038, p = 0.072; general population: b = 0.038, p = 0.005), but negatively associated with atopic sensitization (all: b = −11.256, p = 0.181; patient group: b = −85.667, p < 0.001; general population: b = −14.394, p = 0.083). The relationship between total IgE and GI complaints was consistent among sensitized and non-sensitized persons, among men and women, and across age groups.

Conclusion

Serum total IgE was positively associated with GI complaints, while atopic sensitization was inversely associated with GI complaints. This suggests that IgE-mediated immunology plays a role in the pathophysiology of functional GI complaints. The biological mechanisms reflected in higher total IgE levels, but less atopic sensitization, warrant further studies.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Chang L. Review article: epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Ther. 2004;20:31–39.PubMedCrossRef Chang L. Review article: epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Ther. 2004;20:31–39.PubMedCrossRef
2.
Zurück zum Zitat Chang L, Heitkemper MM. Gender differences in irritable bowel syndrome. Gastroenterology. 2002;123:1686–1701.PubMedCrossRef Chang L, Heitkemper MM. Gender differences in irritable bowel syndrome. Gastroenterology. 2002;123:1686–1701.PubMedCrossRef
3.
Zurück zum Zitat Lied GA. Indication of immune activation in patients with perceived food hypersensitivity. Dig Dis Sci. 2014;59:259–266.PubMedCrossRef Lied GA. Indication of immune activation in patients with perceived food hypersensitivity. Dig Dis Sci. 2014;59:259–266.PubMedCrossRef
4.
Zurück zum Zitat Park MI. Is there a role of food allergy in irritable bowel syndrome and functional dyspepsia? A systematic review. Neurogastroenterol Motil. 2006;18:595–607.PubMedCrossRef Park MI. Is there a role of food allergy in irritable bowel syndrome and functional dyspepsia? A systematic review. Neurogastroenterol Motil. 2006;18:595–607.PubMedCrossRef
5.
Zurück zum Zitat Lillestol K, Helgeland L, Arslan Lied G, et al. Indications of ‘atopic bowel’ in patients with self-reported food hypersensitivity. Aliment Pharmacol Ther. 2010;31:1112–1122.PubMed Lillestol K, Helgeland L, Arslan Lied G, et al. Indications of ‘atopic bowel’ in patients with self-reported food hypersensitivity. Aliment Pharmacol Ther. 2010;31:1112–1122.PubMed
6.
Zurück zum Zitat Bartra J, Sastre J, del Cuvillo A, et al. From pollinosis to digestive allergy. J Investig Allergol Clin Immunol. 2009;19:3–10.PubMed Bartra J, Sastre J, del Cuvillo A, et al. From pollinosis to digestive allergy. J Investig Allergol Clin Immunol. 2009;19:3–10.PubMed
7.
Zurück zum Zitat Matsui EC, Sampson HA, Bahnson HT, et al. Allergen-specific IgE as a biomarker of exposure plus sensitization in inner-city adolescents with asthma. Allergy. 2010;65:1414–1422.PubMedPubMedCentralCrossRef Matsui EC, Sampson HA, Bahnson HT, et al. Allergen-specific IgE as a biomarker of exposure plus sensitization in inner-city adolescents with asthma. Allergy. 2010;65:1414–1422.PubMedPubMedCentralCrossRef
8.
Zurück zum Zitat Lied GA, Lillestol K, Lind R, et al. Perceived food hypersensitivity: a review of 10 years of interdisciplinary research at a reference center. Scand J Gastroenterol. 2011;46:1169–1178.PubMedCrossRef Lied GA, Lillestol K, Lind R, et al. Perceived food hypersensitivity: a review of 10 years of interdisciplinary research at a reference center. Scand J Gastroenterol. 2011;46:1169–1178.PubMedCrossRef
9.
Zurück zum Zitat Tobin MC, Moparty B, Farhadi A, et al. Atopic irritable bowel syndrome: a novel subgroup of irritable bowel syndrome with allergic manifestations. Ann Allergy Asthma Immunol. 2008;100:49–53.PubMedCrossRef Tobin MC, Moparty B, Farhadi A, et al. Atopic irritable bowel syndrome: a novel subgroup of irritable bowel syndrome with allergic manifestations. Ann Allergy Asthma Immunol. 2008;100:49–53.PubMedCrossRef
10.
Zurück zum Zitat Pires GV, Souza HS, Elia CC, et al. Small bowel of patients with asthma and allergic rhinitis: absence of inflammation despite the presence of major cellular components of allergic inflammation. Allergy Asthma Proc. 2004;25:253–259.PubMed Pires GV, Souza HS, Elia CC, et al. Small bowel of patients with asthma and allergic rhinitis: absence of inflammation despite the presence of major cellular components of allergic inflammation. Allergy Asthma Proc. 2004;25:253–259.PubMed
11.
Zurück zum Zitat Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997;11:395–402.PubMedCrossRef Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997;11:395–402.PubMedCrossRef
12.
Zurück zum Zitat Kane SV, Sandborn WJ, Rufo PA, et al. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol. 2003;98:1309–1314.PubMedCrossRef Kane SV, Sandborn WJ, Rufo PA, et al. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol. 2003;98:1309–1314.PubMedCrossRef
14.
Zurück zum Zitat Vanner SJ, Depew WT, Paterson WG, et al. Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome. Am J Gastroenterol. 1999;94:2912–2917.PubMedCrossRef Vanner SJ, Depew WT, Paterson WG, et al. Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome. Am J Gastroenterol. 1999;94:2912–2917.PubMedCrossRef
15.
Zurück zum Zitat Zar S, Kumar D, Benson MJ. Food hypersensitivity and irritable bowel syndrome. Aliment Pharmacol Ther. 2001;15:439–449.PubMedCrossRef Zar S, Kumar D, Benson MJ. Food hypersensitivity and irritable bowel syndrome. Aliment Pharmacol Ther. 2001;15:439–449.PubMedCrossRef
16.
Zurück zum Zitat Stefanini GF, Saggioro A, Alvisi V, et al. Oral cromolyn sodium in comparison with elimination diet in the irritable bowel syndrome, diarrheic type. Multicenter study of 428 patients. Scand J Gastroenterol. 1995;30:535–541.PubMedCrossRef Stefanini GF, Saggioro A, Alvisi V, et al. Oral cromolyn sodium in comparison with elimination diet in the irritable bowel syndrome, diarrheic type. Multicenter study of 428 patients. Scand J Gastroenterol. 1995;30:535–541.PubMedCrossRef
17.
Zurück zum Zitat Stefanini GF, Prati E, Albini MC, et al. Oral disodium cromoglycate treatment on irritable bowel syndrome: an open study on 101 subjects with diarrheic type. Am J Gastroenterol. 1992;87:55–57.PubMed Stefanini GF, Prati E, Albini MC, et al. Oral disodium cromoglycate treatment on irritable bowel syndrome: an open study on 101 subjects with diarrheic type. Am J Gastroenterol. 1992;87:55–57.PubMed
18.
Zurück zum Zitat Powell N, Huntley B, Beech T, et al. Increased prevalence of gastrointestinal symptoms in patients with allergic disease. Postgrad Med J. 2007;83:182–186.PubMedPubMedCentralCrossRef Powell N, Huntley B, Beech T, et al. Increased prevalence of gastrointestinal symptoms in patients with allergic disease. Postgrad Med J. 2007;83:182–186.PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Jones MP, Walker MM, Ford AC, Talley NJ. The overlap of atopy and functional gastrointestinal disorders among 23,471 patients in primary care. Aliment Pharmacol Ther. 2014;40:382–391.PubMedCrossRef Jones MP, Walker MM, Ford AC, Talley NJ. The overlap of atopy and functional gastrointestinal disorders among 23,471 patients in primary care. Aliment Pharmacol Ther. 2014;40:382–391.PubMedCrossRef
20.
Zurück zum Zitat Walker MM, Powell N, Talley NJ. Atopy and the gastrointestinal tract—a review of a common association in unexplained gastrointestinal disease. Expert Rev Gastroenterol Hepatol. 2014;8:289–299.PubMedCrossRef Walker MM, Powell N, Talley NJ. Atopy and the gastrointestinal tract—a review of a common association in unexplained gastrointestinal disease. Expert Rev Gastroenterol Hepatol. 2014;8:289–299.PubMedCrossRef
21.
Zurück zum Zitat Barbara G, Stanghellini V, De Giorgio R, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004;126:693–702.PubMedCrossRef Barbara G, Stanghellini V, De Giorgio R, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004;126:693–702.PubMedCrossRef
22.
Zurück zum Zitat Valeur J, Norin E, Midtvedt T, Berstad A. Assessment of microbial fermentation products in fecal samples. Neurogastroenterol Motil. 2010;22:1147.PubMedCrossRef Valeur J, Norin E, Midtvedt T, Berstad A. Assessment of microbial fermentation products in fecal samples. Neurogastroenterol Motil. 2010;22:1147.PubMedCrossRef
23.
Zurück zum Zitat Barrett JS, Gearry RB, Muir JG, et al. Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Ther. 2010;31:874–882.PubMed Barrett JS, Gearry RB, Muir JG, et al. Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Ther. 2010;31:874–882.PubMed
24.
Zurück zum Zitat Simren M. IBS with intestinal microbial dysbiosis: a new and clinically relevant subgroup? Gut. 2014;63:1685–1686.PubMedCrossRef Simren M. IBS with intestinal microbial dysbiosis: a new and clinically relevant subgroup? Gut. 2014;63:1685–1686.PubMedCrossRef
25.
Zurück zum Zitat Melchior C, Gourcerol G, Dechelotte P, Leroi AM, Ducrotte P. Symptomatic fructose malabsorption in irritable bowel syndrome: a prospective study. United Eur Gastroenterol J. 2014;2:131–137.CrossRef Melchior C, Gourcerol G, Dechelotte P, Leroi AM, Ducrotte P. Symptomatic fructose malabsorption in irritable bowel syndrome: a prospective study. United Eur Gastroenterol J. 2014;2:131–137.CrossRef
27.
Zurück zum Zitat Reginald K, Westritschnig K, Werfel T, et al. Immunoglobulin E antibody reactivity to bacterial antigens in atopic dermatitis patients. Clin Exp Allergy. 2011;41:357–369.PubMedPubMedCentralCrossRef Reginald K, Westritschnig K, Werfel T, et al. Immunoglobulin E antibody reactivity to bacterial antigens in atopic dermatitis patients. Clin Exp Allergy. 2011;41:357–369.PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Klooker TK, Braak B, Koopman KE, et al. The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome. Gut. 2010;59:1213–1221.PubMedCrossRef Klooker TK, Braak B, Koopman KE, et al. The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome. Gut. 2010;59:1213–1221.PubMedCrossRef
Metadaten
Titel
Functional Gastrointestinal Symptoms Are Associated with Higher Serum Total IgE Levels, but Less Atopic Sensitization
verfasst von
Ellen Johanne Vara
Cecilie Svanes
Trude D. Skorge
Aud Berstad
Erik Florvaag
Debbie Jarvis
Ernst Omenaas
Marie Waatevik
Ane Johannessen
Gülen Arslan Lied
Publikationsdatum
01.01.2016
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 1/2016
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-015-3835-1

Weitere Artikel der Ausgabe 1/2016

Digestive Diseases and Sciences 1/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schadet Ärger den Gefäßen?

14.05.2024 Arteriosklerose Nachrichten

In einer Studie aus New York wirkte sich Ärger kurzfristig deutlich negativ auf die Endothelfunktion gesunder Probanden aus. Möglicherweise hat dies Einfluss auf die kardiovaskuläre Gesundheit.

Intervallfasten zur Regeneration des Herzmuskels?

14.05.2024 Herzinfarkt Nachrichten

Die Nahrungsaufnahme auf wenige Stunden am Tag zu beschränken, hat möglicherweise einen günstigen Einfluss auf die Prognose nach akutem ST-Hebungsinfarkt. Darauf deutet eine Studie an der Uniklinik in Halle an der Saale hin.

Klimaschutz beginnt bei der Wahl des Inhalators

14.05.2024 Klimawandel Podcast

Auch kleine Entscheidungen im Alltag einer Praxis können einen großen Beitrag zum Klimaschutz leisten. Die neue Leitlinie zur "klimabewussten Verordnung von Inhalativa" geht mit gutem Beispiel voran, denn der Wechsel vom klimaschädlichen Dosieraerosol zum Pulverinhalator spart viele Tonnen CO2. Leitlinienautor PD Dr. Guido Schmiemann erklärt, warum nicht nur die Umwelt, sondern auch Patientinnen und Patienten davon profitieren.

Zeitschrift für Allgemeinmedizin, DEGAM

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.